Head-to-head · Value Score
Vaylen vs Ro
Two GLP-1 deals, scored on the same six factors. Vaylen lands a Value Score of 87, Ro a 74. Here's who gives you the honest lower price — and where each one bites back.
Vaylen
#21 · Grade A- · Great Deal
Est. first month
$179/mo
Save ~87% vs brand-nameRo
#153 · Grade C+ · Watch List
Est. first month
Not disclosed
The verdict
Vaylen takes it on Value Score, 87 to 74 — an est. $179/mo first month, with no teaser step-up baked in. Ro isn't out of it: Patients who want brand-name access and insurance navigation more than a visible low price.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | Vaylen | Ro |
|---|---|---|
| Value Score | 87 (A-) | 74 (C+) |
| Est. first month | $179/mo | Not disclosed |
| Save vs brand-name | ~87% | — |
| Semaglutide | $179/mo | Not disclosed |
| Tirzepatide | $239/mo | Not disclosed |
| Both molecules | Yes | No |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | Multi-state |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
Vaylen
The most complete menu in the mid-tier: flat pricing, brand-name access, an oral route, and a LegitScript pharmacy.
Why it's a deal
- LegitScript-certified with all-50-state reach
- Offers compounded, FDA-approved brand-name, and oral routes
- Flat $179 sema / $239 tirz — no teaser step-up
The fine print
- Pricing is mid-pack, not rock-bottom
- You pay for the breadth of options
Ro
A heavyweight platform with brand-name access — but it won't show a compounded price until you're in the funnel.
Why it's a deal
- Brand-name (Wegovy/Zepbound) access and insurance support
- Oral options
- Polished, well-funded platform
The fine print
- Does not publish compounded pricing up front — no way to compare the deal
- Premium positioning
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores Vaylen is ranked on the Vaylen alternatives ranking, and the same list for the other side is on alternatives to Ro.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.